文献速递糖尿病肥胖与代谢综合征

痛风是2型糖尿病患者下肢截肢的独立危险因素

Gout as a risk factor for lower-extremity amputation in diabetes: a nationwide, register-based case-control study.
PubMed 文献 · Diabetologia · 2026-11-03

该研究基于全国登记数据,在601,541例2型糖尿病患者中纳入4912例下肢截肢(LEA)病例与39,101名年龄性别匹配对照,评估痛风与LEA的关联。结果显示,充分校正后痛风仍与LEA风险升高独立相关(OR 1.53,95%CI 1.37,1.69),且截肢部位越远端风险可能越高。

要点

  • 痛风使2型糖尿病患者下肢截肢风险升高约五成,独立于周围动脉疾病等并发症。
  • 截肢部位越远端风险可能越高,趾部截肢OR高于膝上截肢。
  • 管理有截肢风险的2型糖尿病患者时需提高对痛风的警惕。

核心结论

  • 合并痛风是2型糖尿病患者下肢截肢的独立危险因素,风险在各截肢水平均升高,远端部位效应可能更明显。

研究设计与样本

  • 全国性登记为基础的病例对照研究,覆盖601,541例2型糖尿病患者,含4912例LEA病例与39,101名年龄性别匹配对照。
  • 痛风暴露依据ICD-10诊断及降尿酸治疗的ATC编码判定。
  • 采用条件logistic回归,校正糖尿病病程、周围动脉疾病、急性心肌梗死及晚期糖尿病并发症。

主要发现

  • 未校正分析中痛风与LEA风险升高相关(OR 1.85,95%CI 1.69,2.02)。
  • 充分校正后关联仍显著(OR 1.53,95%CI 1.37,1.69)。
  • 截肢水平间存在显著趋势(p=0.03):膝上截肢OR 1.37(95%CI 1.12,1.68),趾部截肢OR 1.65(95%CI 1.32,2.05),但各水平间差异无统计学意义。

临床怎么用

  • 对合并痛风的2型糖尿病患者应加强下肢截肢风险评估与足部管理。
  • 在评估截肢风险时可将痛风纳入考量,重视降尿酸治疗在整体管理中的作用。

局限性

  • 研究为观察性设计,残余混杂难以完全排除。
  • 痛风暴露依赖诊断编码与用药记录,可能存在错分。
  • 各截肢水平间差异未达统计学显著,远端风险更高的结论需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Non-healing diabetic foot ulcers are a major precursor to lower-extremity amputation (LEA) in diabetes, and gout may be an overlooked contributor. We hypothesised that individuals with both diabetes and gout have a higher risk of LEA than those with diabetes alone, with the strongest effect at more distal amputation levels. METHODS: In a nationwide case-control study of 601,541 individuals with type 2 diabetes, we identified 4912 cases with LEA and 39,101 age- and sex-matched control participants. Gout exposure was determined using ICD-10 diagnoses and Anatomical Therapeutic Chemical codes for urate-lowering therapy. Associations were estimated using conditional logistic regression, adjusting for diabetes duration, peripheral arterial disease, acute myocardial infarction and late diabetes complications. RESULTS: Gout was associated with an increased risk of LEA (OR 1.85, 95% CI 1.69, 2.02) in unadjusted analyses, and the association remained significant after full adjustment (OR 1.53, 95% CI 1.37, 1.69). A significant trend (p=0.03) was observed across amputation levels, with potentially higher risk at more anatomically distal sites although no statistically significant differences were observed between individual amputation levels: OR 1.37 (95% CI 1.12, 1.68) for above-knee amputations, increasing to OR 1.65 (95% CI 1.32, 2.05) for toe amputations. CONCLUSIONS/INTERPRETATION: Co-existing gout is an independent risk factor for LEA in individuals with type 2 diabetes. The risk is elevated across all amputation levels, with the most pronounced effect potentially being at distal anatomical sites. These findings highlight the need for increased awareness of gout when managing individuals with type 2 diabetes at risk of LEA.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Røikjer J, Kvist AV, Leutscher PDC, et al. Gout as a risk factor for lower-extremity amputation in diabetes: a nationwide, register-based case-control study. Diabetologia. 2026. PMID: 42975645. doi:10.1007/s00125-026-06920-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。